Akshaya Srikanth Bhagavathula1, Cain C T Clark2, Jamal Rahmani3, Vijay Kumar Chattu4,5. 1. Department of Social and Clinical Pharmacy, Faculty of Pharmacy, Univerziti Kralova, 500 03 Hradec Kralova, Czech Republic. 2. Centre for Intelligent Healthcare, Coventry University, Coventry CV1 5FB, UK. 3. Department of Community Nutrition, Faculty of Nutrition and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran 198396-3113, Iran. 4. Division of Occupational Medicine, Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, ON M5G 2C4, Canada. 5. Occupational Medicine Clinic, St. Michael's Hospital, Unity Health Toronto, Toronto, ON M5C 2C5, Canada.
Abstract
BACKGROUND: A growing trove of literature describes the effect of malnutrition and underweight on the incidence of inflammatory bowel disease (IBD). However, evidence regarding the association between underweight or obesity and IBD is limited. The study aimed to assess the association of body mass index (BMI) with a risk of IBD (Crohn's disease (CD) and ulcerative colitis (U.C.)) incidence. METHODS: We systematically searched PubMed/Medline, Cochrane, Web of Science, and Scopus for observational studies assessing the association between BMI and IBD that were published up to 30 June 2020. We estimated pooled hazard ratios (HR) with corresponding 95% confidence intervals (CI). Random effect dose-response meta-analysis was performed using the variance weighted least-squares regression (VWLS) models to identify non-linear associations. RESULTS: A total of ten studies involving 15.6 million individuals and 23,371 cases of IBD were included. Overall, obesity was associated with an increased IBD risk (HR: 1.20, 95% CI: 1.08-1.34, I 2 = 0%). Compared to normal weight, underweight (BMI < 18.5 kg/m2) and obesity (BMI ≥ 30 kg/m2) were associated with a higher risk of CD, and there was no difference in the risk of U.C. among those with BMI < 18.5 kg/m2 and BMI ≥ 30 kg/m2. There was a significant non-linear association between being underweight and obesity and the risk of development of CD (Coef1 = -0.0902, p 1 < 0.001 Coef2 = 0.0713, p 2 < 0.001). CONCLUSIONS: Obesity increases the risk of IBD development. Underweight and obesity are independently associated with an increased risk of CD, yet there is no evident association between BMI and the risk of U.C. Further studies are needed to clarify the underlying mechanism for these findings, particularly in CD.
BACKGROUND: A growing trove of literature describes the effect of malnutrition and underweight on the incidence of inflammatory bowel disease (IBD). However, evidence regarding the association between underweight or obesity and IBD is limited. The study aimed to assess the association of body mass index (BMI) with a risk of IBD (Crohn's disease (CD) and ulcerative colitis (U.C.)) incidence. METHODS: We systematically searched PubMed/Medline, Cochrane, Web of Science, and Scopus for observational studies assessing the association between BMI and IBD that were published up to 30 June 2020. We estimated pooled hazard ratios (HR) with corresponding 95% confidence intervals (CI). Random effect dose-response meta-analysis was performed using the variance weighted least-squares regression (VWLS) models to identify non-linear associations. RESULTS: A total of ten studies involving 15.6 million individuals and 23,371 cases of IBD were included. Overall, obesity was associated with an increased IBD risk (HR: 1.20, 95% CI: 1.08-1.34, I 2 = 0%). Compared to normal weight, underweight (BMI < 18.5 kg/m2) and obesity (BMI ≥ 30 kg/m2) were associated with a higher risk of CD, and there was no difference in the risk of U.C. among those with BMI < 18.5 kg/m2 and BMI ≥ 30 kg/m2. There was a significant non-linear association between being underweight and obesity and the risk of development of CD (Coef1 = -0.0902, p 1 < 0.001 Coef2 = 0.0713, p 2 < 0.001). CONCLUSIONS:Obesity increases the risk of IBD development. Underweight and obesity are independently associated with an increased risk of CD, yet there is no evident association between BMI and the risk of U.C. Further studies are needed to clarify the underlying mechanism for these findings, particularly in CD.
Entities:
Keywords:
Crohn’s disease; body mass index; dose-response analysis; inflammatory bowel disease; meta-analysis; obesity; systematic review
Authors: Konstantinos Karmiris; Ioannis E Koutroubakis; Costas Xidakis; Maria Polychronaki; Theodora Voudouri; Elias A Kouroumalis Journal: Inflamm Bowel Dis Date: 2006-02 Impact factor: 5.325
Authors: Hamed Khalili; Ashwin N Ananthakrishnan; Gauree G Konijeti; Leslie M Higuchi; Charles S Fuchs; James M Richter; Andrew T Chan Journal: Inflamm Bowel Dis Date: 2015-02 Impact factor: 5.325
Authors: Simon S M Chan; Robert Luben; Anja Olsen; Anne Tjonneland; Rudolf Kaaks; Birgit Teucher; Stefan Lindgren; Olof Grip; Timothy Key; Francesca L Crowe; Manuela M Bergmann; Heiner Boeing; Göran Hallmans; Pontus Karling; Kim Overvad; Domenico Palli; Giovanna Masala; Hugh Kennedy; Fiona vanSchaik; Bas Bueno-de-Mesquita; Bas Oldenburg; Kay-Tee Khaw; Elio Riboli; Andrew R Hart Journal: Am J Gastroenterol Date: 2013-01-15 Impact factor: 10.864
Authors: Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher Journal: BMJ Date: 2009-07-21
Authors: F Scaldaferri; M Pizzoferrato; L R Lopetuso; T Musca; F Ingravalle; L L Sicignano; M Mentella; G Miggiano; M C Mele; E Gaetani; C Graziani; V Petito; G Cammarota; E Marzetti; A Martone; F Landi; A Gasbarrini Journal: Gastroenterol Res Pract Date: 2017-01-03 Impact factor: 2.260
Authors: Jan Bilski; Agnieszka Mazur-Bialy; Dagmara Wojcik; Marcin Surmiak; Marcin Magierowski; Zbigniew Sliwowski; Robert Pajdo; Slawomir Kwiecien; Aleksandra Danielak; Agata Ptak-Belowska; Thomas Brzozowski Journal: Biomolecules Date: 2019-11-26
Authors: Timon E Adolph; Moritz Meyer; Julian Schwärzler; Lisa Mayr; Felix Grabherr; Herbert Tilg Journal: Nat Rev Gastroenterol Hepatol Date: 2022-07-29 Impact factor: 73.082
Authors: Antonio F Di Narzo; Amy Hart; Roman Kosoy; Lauren Peters; Aleksandar Stojmirovic; Haoxiang Cheng; Zhongyang Zhang; Mingxu Shan; Judy Cho; Andrew Kasarskis; Carmen Argmann; Inga Peter; Eric E Schadt; Ke Hao Journal: Hum Mol Genet Date: 2021-04-30 Impact factor: 6.150
Authors: Eva Karaskova; Maria Velganova-Veghova; Milos Geryk; Hana Foltenova; Veronika Kucerova; David Karasek Journal: Int J Mol Sci Date: 2021-04-19 Impact factor: 5.923